Join to access to all OVN content. Join for Free
HOLD MY BEER… I’m Going to be an MSL
Medical Science Liaison career transition mentorship networking transferable skills

HOLD MY BEER… I’m Going to be an MSL


Share This Article


Summary

In this episode, Lana Lucidi shares her journey from early career roles to becoming a Medical Science Liaison. She delves into her transition process, highlighting the importance of mentorship, networking, and leveraging transferable skills. Lana addresses common challenges faced when pursuing an MSL role, particularly navigating job descriptions and targeting the right companies. She offers valuable advice for aspiring MSLs, emphasizing the significance of building expertise and confidence, especially when engaging with Key Opinion Leaders (KOLs). The episode concludes with reflections on the MSL role, the impact of the MSL Talk podcast, and words of encouragement for those on the MSL path.

My guest this week is Lana Luccitti, Medical Science Liaison with Topcon Health who discusses how it is possible to land an MSL role without a Doctorate.

Lana shares…

👉 What made her want to be an MSL
👉 The first thing she did in her MSL Search
👉 The frustrations she had along the way
👉 What helped her stand out from others
👉 Most important advice she can offer

Click for Source
Medical Science Liaison, career transition, mentorship, networking, transferable skills

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Surround to Succeed: Building a Motivational Network
Partner Avatar MSL Talk: Tom Caravela, Sarah Snyder

Surround to Succeed: Building a Motivational Network

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Explore OVN